NanoHorizons Inc., maker of SmartSilver™ antimicrobial additives for textile, health care and industrial applications, has completed its planned $3.5 million second-phase funding from the company’s spring 2008 Series B preferred equity offering.

STATE COLLEGE, PA – NanoHorizons Inc., maker of SmartSilver™ antimicrobial additives for textile, health care and industrial applications, has completed its planned $3.5 million second-phase funding from the company’s spring 2008 Series B preferred equity offering.
 
“With the completion of this anticipated phase of funding, we will continue to expand the product, business and research development activities that have successfully fueled the growth of SmartSilver as a uniquely effective antimicrobial brand,” said David A. Woodle, Chairman and CEO of NanoHorizons. “We appreciate our investors’ support and enthusiasm for both our company and our products.”
 
NanoHorizons’ SmartSilver antimicrobial additives are engineered to integrate silver nanoparticles at the molecular level, providing permanent, cost-effective and environmentally friendly anti-bacterial, anti-fungal and anti-odor protection that never wears off or washes out, lasting the life of the end product.